Status:
UNKNOWN
Telehealth Program to Prevent Cancer and Chemotherapy-related Cognitive Impairment.
Lead Sponsor:
Universidad de Granada
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
The present randomized controlled trial has the main objective to study the effects of a videoconferenced occupational therapy program in preventing cancer and chemotherapy-related cognitive impairmen...
Detailed Description
The chemotherapy-related cognitive impairment (also called chemobrain) has a great incidence among breast cancer population. However, the knowledge about effective interventions of supportive care is ...
Eligibility Criteria
Inclusion
- Female with breast cancer who are going to start chemotherapy
- Stage I-III breast cancer
- No evidence of disease at time of screening
- Must be able to speak, read and write Spanish well to complete written and verbal assessment, neurocognitive tests and study tasks
- Must have basic phone skills
Exclusion
- History of neurological disorder with cognitive symptoms (i.e., Parkinson's disease, Alzheimer disease, seizure disorder, multiple sclerosis, etc.)
- History of psychiatric disorder such as mental retardation, bipolar disorder, schizophrenia, etc.
- History of traumatic brain injury with ≥ 30' of consciousness or cognitive sequelae as per self-report or as documented in the medical record
- Prior history of cancer or secondary diagnosis of cancer
- Prior history of chemotherapy
- A hearing or visual deficit
Key Trial Info
Start Date :
October 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT04783402
Start Date
October 31 2020
End Date
December 30 2024
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Granada
Granada, Spain, 18016